Biolife solutions CFO sells shares worth $26,668

Published 09/01/2025, 01:14
Biolife solutions CFO sells shares worth $26,668
BLFS
-

The sale was made under a pre-established Rule 10b5-1 trading plan, which Wichterman adopted to manage tax obligations related to the vesting of restricted stock. InvestingPro subscribers can access 12 additional key insights and a comprehensive Pro Research Report for deeper analysis of BLFS’s financial health and market position. InvestingPro subscribers can access 12 additional key insights and a comprehensive Pro Research Report for deeper analysis of BLFS’s financial health and market position.

The sale was made under a pre-established Rule 10b5-1 trading plan, which Wichterman adopted to manage tax obligations related to the vesting of restricted stock.

In other recent news, BioLife Solutions (NASDAQ:BLFS) has been the focus of several analyst adjustments following significant strategic shifts. Maxim Group raised its price target for BioLife Solutions to $34, anticipating a return to durable top-line growth by 2025, largely due to the company’s increased focus on its Cell and Gene Therapy tools. KeyBanc Capital Markets also maintained an Overweight rating for BioLife Solutions, citing confidence in the company’s growth prospects following the appointment of Tony Hunt to the Board of Directors.

Benchmark maintained a Buy rating on BioLife Solutions’ shares, despite revising fourth-quarter revenue projections downwards, due to the company’s strategic sale of its SciSafe biostorage service division. KeyBanc Capital Markets also increased its price target to $33, praising the company’s successful execution of three asset sales and its dominance in the freeze media sector for cell, gene, and CAR-T therapies.

H.C. Wainwright, however, reduced its price target for BioLife Solutions to $27, following the company’s divestiture of its freezer subsidiary, Arctic Solutions, and its biostorage subsidiary, SciSafe Holdings. Despite these divestitures, BioLife Solutions raised its cell processing revenue guidance for 2024, signaling a successful transition towards a business model centered on consumable, recurring revenue streams with higher margin potential.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.